Form 4: Cartesian Therapeutics Director Gifts 20,000 Shares
Insider Transaction Report
Michael Singer, a Director at Cartesian Therapeutics, Inc., reported gifting 20,000 shares of common stock on November 18, 2025.
Summary
- Michael Singer, a Director of Cartesian Therapeutics, Inc. (RNAC), reported a gift transaction.
- On November 18, 2025, Singer disposed of 20,000 shares of common stock via a gift (Transaction Code G) at a price of $0.
- Following this transaction, Singer directly beneficially owns 53,533 shares of common stock.
- Indirect beneficial ownership includes 383,796 shares held in a trust for his spouse and children, 56,719 shares in a trust where he is a beneficiary and trustee, 7,127 shares in another trust where he is a beneficiary and his spouse is a trustee, 14,788 shares held by his spouse, and 96,219 shares each held as custodian for two children (LS and SS) under Uniform Transfer to Minors Act (UTMA) accounts.
- Total beneficial ownership after the transaction is 708,401 shares (53,533 direct + 654,868 indirect).
Sentiment
Score: 5
Explanation: The filing reports a routine insider gift transaction, which is neutral in terms of company performance or outlook. It reflects a change in beneficial ownership but not a market-driven sale or purchase.
Future Outlook
This filing does not contain any forward-looking statements or guidance.
Industry Context
This is a routine insider transaction disclosure, common across all industries for publicly traded companies. It does not provide specific industry context or insights into broader industry trends.
Related Party Transactions
- Michael Singer, a Director, gifted 20,000 shares of common stock to family-related trusts and directly to his spouse and children's custodial accounts, which are considered related parties.
Stakeholder Impact
- Shareholders: The transaction represents a minor change in the beneficial ownership structure of a director, with no direct impact on the company's operations or financial health. It does not dilute existing shares or generate capital for the company.
- Employees, Customers, Suppliers, Creditors: No direct impact from this insider gift transaction.
Key Dates
| Date | Description |
|---|---|
| 11/18/2025 | Date of earliest transaction (gift of common stock) |
| 11/19/2025 | Signature date of the reporting person's attorney-in-fact |
Keywords
Cartesian Therapeutics, RNAC, Michael Singer, Director, SEC Form 4, Insider Transaction, Stock Gift, Beneficial Ownership, Common Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.